ArticleScientific reports2026
Prevalence of Pseudomonas aeruginosa in Australian wild birds, native wildlife, livestock and domestic animals.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of Pseudomonas aeruginosa in Australian wild birds, native wildlife, livestock and domestic animals.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The ESKAPE pathogen, Pseudomonas aeruginosa, poses a serious threat to medical, veterinary, and agricultural practices globally, and thus has been declared a “Priority Pathogen” by the World Health Organisation. Understanding P. aeruginosa prevalence in wild bird populations, livestock, and domestic animals is vital for evaluating potential infection reservoirs. In this study, we screened 1,669 DNA samples obtained between 2010 and 2023 from healthy and diseased wild birds (n = 1,101), domestic animals (n = 269), livestock (n = 133), kangaroos (n = 39), and koalas (n = 127) from Southeast Queensland, Australia, for both P. aeruginosa and overall bacterial load using an ecfX-16 S rRNA duplex real-time PCR assay. P. aeruginosa-positive samples were also screened for the two most common fluoroquinolone resistance genotypes, GyrA Thr83Ile and GyrA Asp87Asn. Overall, only 1.8% of samples from our large and diverse sample set tested positive for P. aeruginosa. Livestock samples showed the highest P. aeruginosa prevalence (4.5%, n = 6), driven primarily by horses (7.4%, n = 5), with wild birds (1.5%, n = 17), koalas (1.6%, n = 2), and domestic animals (1.9%, n = 5) having the next highest rates. In contrast, no P. aeruginosa positive samples were identified in cattle (n = 45) or kangaroos (n = 39). Nearly all positive wild bird samples originated from eye swabs (94%, n = 16). No additional correlation between swab site, health status, or admission cause was identified. No GyrA Asp87Asn variants were seen; however, the GyrA Thr83Ile variant was seen in 2/30 (6.6%) P. aeruginosa-positive samples, both of horse origin. This finding suggests the presence of a fluoroquinolone resistant subpopulation, however confirmation through phenotypic resistance profiling was unable to be performed. Our findings provide important insight into the epidemiology of P. aeruginosa in Australian wildlife and domestic animal populations from South-East Queensland. Further prevalence studies, particularly covering a broader geographical region, are warranted to better elucidate nationwide P. aeruginosa carriage, infection, and fluoroquinolone resistance rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.